Epigenetic Drug Boosts Blood Vessel Health by Targeting Fat
Researchers at the University of Zurich have identified a potential breakthrough in treating cardiometabolic disease by targeting the thin layer of fat surrounding blood vessels. According to a study published in Cell Reports, using a BET inhibitor to suppress a specific enzyme in this fat layer reduces inflammation and restores the ability of arteries to … Read more